Scarica l'app Stockscreener
2.36
0.00%
0.00
Dopo l'orario di chiusura:
2.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Precedente Chiudi:
$2.36
Aprire:
$2.36
Volume 24 ore:
529.51K
Relative Volume:
0.33
Capitalizzazione di mercato:
$341.44M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-2.6208
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
-0.84%
1M Prestazione:
+3.96%
6M Prestazione:
-16.90%
1 anno Prestazione:
-71.15%
Intervallo 1D:
$2.30
$2.3836
Intervallo di 1 settimana:
$2.285
$2.45
Portata 52W:
$1.665
$9.60
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Nome
Maravai Lifesciences Holdings Inc
Settore
Industria
Telefono
(858) 546-0004
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Confronta MRVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.36 | 342.89M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Neutral |
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Iniziato | Craig Hallum | Buy |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-08-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Downgrade | Goldman | Buy → Neutral |
| 2023-01-05 | Downgrade | UBS | Buy → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-11-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-12-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Iniziato | Credit Suisse | Outperform |
| 2020-12-15 | Iniziato | Goldman | Buy |
| 2020-12-15 | Iniziato | Jefferies | Buy |
| 2020-12-15 | Iniziato | Robert W. Baird | Outperform |
| 2020-12-15 | Iniziato | Stifel | Buy |
| 2020-12-15 | Iniziato | William Blair | Outperform |
| 2020-12-14 | Iniziato | UBS | Buy |
Mostra tutto
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
What the charts say about Maravai LifeSciences Holdings Inc. todayShare Buyback & High Accuracy Trade Alerts - Newser
Will a bounce in Maravai LifeSciences Holdings Inc. offer an exit2025 Key Highlights & Detailed Earnings Play Alerts - Newser
Analyzing net buyer seller activity in Maravai LifeSciences Holdings Inc.Quarterly Trade Review & Risk Controlled Daily Plans - Newser
Can trapped investors hope for a rebound in Maravai LifeSciences Holdings Inc.July 2025 Action & Risk Controlled Swing Trade Alerts - Newser
Will Maravai LifeSciences Holdings Inc. see short term momentumJuly 2025 Recap & AI Enhanced Trading Alerts - Newser
Is Maravai LifeSciences Holdings Inc. being accumulated by smart moneyJuly 2025 Trade Ideas & Capital Efficient Trade Techniques - khodrobank.com
Using data tools to time your Maravai LifeSciences Holdings Inc. exit2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Is Maravai LifeSciences Holdings Inc. reversing from oversold territoryInflation Watch & Real-Time Chart Pattern Alerts - Newser
Will Maravai LifeSciences Holdings Inc. stock recover after recent dropJuly 2025 Action & Pattern Based Trade Signal System - Newser
Head to Head Contrast: Cytosorbents (NASDAQ:CTSO) vs. Maravai LifeSciences (NASDAQ:MRVI) - Defense World
Full technical analysis of Maravai LifeSciences Holdings Inc. stockJuly 2025 PostEarnings & Fast Entry Momentum Trade Alerts - Newser
Top chart patterns to watch in Maravai LifeSciences Holdings Inc.IPO Watch & Low Risk Investment Opportunities - Newser
Should you hold or exit Maravai LifeSciences Holdings Inc. nowRecession Risk & AI Based Trade Execution Alerts - Newser
Can momentum traders help lift Maravai LifeSciences Holdings Inc.Market Growth Report & Fast Momentum Entry Tips - Newser
Will Maravai LifeSciences Holdings Inc. price bounce be sustainableGold Moves & Breakout Confirmation Trade Signals - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect - ACCESS Newswire
Can a trend reversal in Maravai LifeSciences Holdings Inc. lead to recoveryEarnings Performance Report & Real-Time Chart Breakout Alerts - Newser
Using fundamentals and technicals on Maravai LifeSciences Holdings Inc.Weekly Profit Recap & AI Optimized Trade Strategies - Newser
What hedge funds are buying Maravai LifeSciences Holdings Inc.July 2025 Opening Moves & Fast Gain Swing Alerts - khodrobank.com
Maravai LifeSciences Holdings Inc. stock daily chart insightsMarket Trend Summary & Verified Entry Point Detection - Newser
What technical models suggest about Maravai LifeSciences Holdings Inc.’s comebackTrade Entry Report & Reliable Price Action Trade Plans - Newser
How does Maravai LifeSciences Holdings Inc. perform in inflationary periodsJuly 2025 Movers & Daily Volume Surge Trade Alerts - khodrobank.com
Order flow analysis tools used on Maravai LifeSciences Holdings Inc.Share Buyback & Stock Portfolio Risk Management - Newser
Charles Schwab Investment Management Inc. Increases Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI - Defense World
Maravai Lifesciences' Q2 Earnings Call: Mixed Bag with Promising Growth and Financial Challenges - AInvest
Published on: 2025-09-01 10:46:50 - Newser
Visual analytics tools that track Maravai LifeSciences Holdings Inc. performance2025 Top Gainers & Step-by-Step Trade Execution Guides - Newser
Maravai Lifesciences’ Earnings Call: Growth Amid Challenges - TipRanks
Is Maravai LifeSciences Holdings Inc. meeting your algorithmic filter criteria2025 Market Outlook & Intraday High Probability Setup Alerts - Newser
Maravai LifeSciences Holdings Inc. stock trend forecastEarnings Trend Report & Real-Time Market Sentiment Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Short interest data insights for Maravai LifeSciences Holdings Inc.Oil Prices & AI Forecast Swing Trade Picks - Newser
What machine learning models say about Maravai LifeSciences Holdings Inc.2025 Investor Takeaways & Daily Technical Stock Forecast Reports - Newser
Published on: 2025-08-31 03:07:57 - Newser
Developing predictive dashboards with Maravai LifeSciences Holdings Inc. dataBuy Signal & Free Accurate Trade Setup Notifications - Newser
What candlestick patterns are forming on Maravai LifeSciences Holdings Inc.2025 Top Gainers & AI Enhanced Execution Alerts - Newser
Building trade automation scripts for Maravai LifeSciences Holdings Inc.Weekly Risk Report & Weekly Stock Performance Updates - Newser
Live Scanner Shows Breakout on Maravai LifeSciences Holdings Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):